The pharmaceutical creation pipeline represents a remarkably challenging and costly undertaking. It typically commences with initial discovery efforts, often involving evaluating thousands of compounds to identify potential pharmaceutical agents. Following this, initial evaluations are performed in vitro and in animal models to assess harmlessness